IO Biotech, Inc. (IOBTQ) vs Lipella Pharmaceuticals Inc. (LIPO)

IO Biotech, Inc. and Lipella Pharmaceuticals Inc. are both Biotechnology companies. IO Biotech, Inc. and Lipella Pharmaceuticals Inc. are of similar size ($3.5M and $3.4M). Across the 8 metrics below, IO Biotech, Inc. leads on 4 and Lipella Pharmaceuticals Inc. on 4.

Valuation

Metric IOBTQ LIPO Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.15 0.31 0.74
EV/Sales n/m (3.61) 10.73
Earnings yield 0.00% 0.00% (28.84%)
Free cash flow yield 0.00% 0.00% (23.03%)

Profitability

Metric IOBTQ LIPO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (240.48%) (361.77%) (57.72%)
Return on assets (136.03%) (236.36%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IOBTQ LIPO Biotechnology median
Revenue growth (TTM) — (7.29%) 5.64%
EPS growth (last fiscal year) 26.77% 22.24% —
Revenue growth, 5-year CAGR — (5.04%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IOBTQ LIPO Biotechnology median
Debt to equity 18.29 0.00 0.00
Current ratio 2.01 3.24 4.73
Net debt to EBITDA 0.63 0.43 0.96

Dividend

Metric IOBTQ LIPO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric IOBTQ LIPO Biotechnology median
Market cap 3.45m 3.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack